Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
16
REMYY Quote, Financials, Valuation and Earnings
Last price:
$5.95
Seasonality move
:
-0.94%
Day range:
$5.96 - $6.04
52-week range:
$5.54 - $12.77
Dividend yield:
8.9%
P/E ratio:
17.24x
P/S ratio:
2.59x
P/B ratio:
1.47x
Volume:
31.2K
Avg. volume:
39.4K
1-year change:
-52.09%
Market cap:
$3.1B
Revenue:
$1.3B
EPS (TTM):
$0.35
Analysts' Opinion
-
Consensus RatingRemy Cointreau has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Remy Cointreau has an estimated downside of -- from its current price of $6.02.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $6.02.
Fair Value
-
According to the consensus of 0 analysts, Remy Cointreau has -- downside to fair value with a price target of -- per share.
REMYY vs. S&P 500
-
Over the past 5 trading days, Remy Cointreau has underperformed the S&P 500 by -7.12% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Remy Cointreau does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Remy Cointreau has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Remy Cointreau reported revenues of --.
Earnings Growth
-
Remy Cointreau has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Remy Cointreau reported earnings per share of --.
Enterprise value:
3.8B
EV / Invested capital:
1.33x
Price / LTM sales:
2.59x
EV / EBIT:
13.22x
EV / Revenue:
3.19x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.94x
Price / Operating cash flow:
17.01x
Enterprise value / EBITDA:
11.24x
Gross Profit (TTM):
$849.3M
Return On Assets:
4.82%
Net Income Margin (TTM):
15.03%
Return On Equity:
8.96%
Return On Invested Capital:
6.42%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2017-03-31 | 2018-03-31 | 2019-03-31 | 2018-03-31 | 2019-03-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1.4B | $1.3B | -- | -- | |
| Gross Profit | $795.6M | $915.2M | $816.3M | -- | -- | |
| Operating Income | $247.2M | $284.2M | $303.3M | -- | -- | |
| EBITDA | $252.9M | $283.6M | $325M | -- | -- | |
| Diluted EPS | $0.40 | $0.34 | $0.35 | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $2.2B | $2.1B | $2.7B | $2.6B | |
| Total Assets | $3.1B | $3.3B | $3.1B | $3.8B | $3.8B | |
| Current Liabilities | $733.8M | $974.5M | $998.5M | $1.1B | $992.1M | |
| Total Liabilities | $1.4B | $1.4B | $1.4B | $1.9B | $1.6B | |
| Total Equity | $1.7B | $1.8B | $1.7B | $1.9B | $2.1B | |
| Total Debt | $584.1M | $444.6M | $413.9M | $882.2M | $736.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-24 | 2023-12-24 | 2023-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
REMYY
Sector
Market Cap
$3.1B
$347.3M
Price % of 52-Week High
47.1%
73.63%
Dividend Yield
8.9%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-52.09%
-13.33%
Beta (5-Year)
0.651
0.504
Dividend yield:
8.9%
Annualized payout:
$0.31
Payout ratio:
--
Growth streak:
3 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.26
200-day SMA
Sell
Level
$8.02
Bollinger Bands (100)
Sell
Level
6.08 - 7.56
Chaikin Money Flow
Buy
Level
4.8M
20-day SMA
Sell
Level
$6.25
Relative Strength Index (RSI14)
Sell
Level
42.53
ADX Line
Sell
Level
4.82
Williams %R
Buy
Level
-93.4524
50-day SMA
Sell
Level
$6.19
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-3.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Buy
CA Score
(Annual)
Level (0.2941)
Buy
Beneish M-Score
(Annual)
Level (-2.4044)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.9248)
Buy
Piotroski F Score
(Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Remy Cointreau is the world’s second-largest distiller of cognac by volume, with a 15.8% global volume share in 2022, according to Euromonitor. Cognac represented 72% of Remy's sales and 90% of EBIT in the same year. The remainder of Remy’s portfolio is made up of much smaller group-owned brands, including Cointreau orange liqueur, Metaxa Greek spirit, Mount Gay rum, Bruichladdich single malt scotch, The Botanist gin, Hautes Glaces French whiskey, and Westland American whiskey. The company also distributes third-party brands and, in 2023, entered the fragrance business. Remy is controlled by the Andromede family, which owns 41% equity interest and consolidates the business in the Andromede Group. The Cointreau family owns a further 27%, and 41% of the equity is free float.
Stock Forecast FAQ
In the current month, REMYY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The REMYY average analyst price target in the past 3 months is --.
-
Where Will Remy Cointreau Stock Be In 1 Year?
According to analysts, the consensus estimate is that Remy Cointreau share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Remy Cointreau?
Analysts are divided on their view about Remy Cointreau share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Remy Cointreau is a Sell and believe this share price will rise from its current level to --.
-
What Is Remy Cointreau's Price Target?
The price target for Remy Cointreau over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is REMYY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Remy Cointreau is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of REMYY?
You can purchase shares of Remy Cointreau via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Remy Cointreau shares.
-
What Is The Remy Cointreau Share Price Today?
Remy Cointreau was last trading at $5.95 per share. This represents the most recent stock quote for Remy Cointreau. Yesterday, Remy Cointreau closed at $6.02 per share.
-
How To Buy Remy Cointreau Stock Online?
In order to purchase Remy Cointreau stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.46% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.66% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.53% over the past day.
